Here is a comprehensive overview of both drugs and their combination:
Paracetamol 650 mg + Levocetirizine Dihydrochloride
This is a common fixed-dose combination (FDC) used in cold, flu, and allergic conditions presenting with fever, pain, and allergic symptoms simultaneously.
1. Paracetamol (Acetaminophen) 650 mg
Pharmacology
- Class: Non-opioid analgesic / Antipyretic
- Mechanism: Inhibits prostaglandin synthesis centrally (COX-3 pathway); also activates descending serotonergic pathways. Lacks significant peripheral anti-inflammatory action.
- Onset: 30–60 minutes (oral); Peak effect: 1–2 hours
Indications
- Fever (antipyretic)
- Mild to moderate pain — headache, myalgia, dental pain, post-operative pain
- Symptomatic relief in dengue, chikungunya, influenza (preferred over NSAIDs in these viral conditions)
Dosage
| Population | Dose |
|---|
| Adults | 500–1000 mg every 4–6 hours |
| Max daily dose | 4000 mg/day (3000 mg/day in elderly, liver disease, alcohol users) |
| The 650 mg dose | A common extended-release or IR formulation given TID–QID |
The 650 mg dose is widely used in India and Asia as a higher unit dose for more effective analgesia/antipyresis while staying within daily limits.
Adverse Effects
- Generally well tolerated at therapeutic doses
- Hepatotoxicity is the major concern — dose-dependent; risk increased with alcohol use, malnutrition, liver disease
- Rare: allergic skin reactions, thrombocytopenia
Contraindications
- Severe hepatic impairment
- Known hypersensitivity to paracetamol
- Chronic alcoholism (relative)
2. Levocetirizine Dihydrochloride
Pharmacology
- Class: Second-generation antihistamine (H₁-receptor antagonist)
- Mechanism: Levocetirizine is the active R-enantiomer of cetirizine. It selectively and competitively blocks peripheral H₁ receptors, reducing histamine-mediated effects. It is less lipophilic than first-generation antihistamines, resulting in minimal CNS penetration and low sedation.
- Onset: ~1 hour; Half-life: ~6–10 hours
- Protein binding: ~91–92%
- Excretion: Primarily renal (~85% unchanged in urine)
Indications
(Per Harrison's Principles of Internal Medicine)
- Allergic rhinitis (seasonal and perennial)
- Chronic urticaria / idiopathic urticaria
- Allergic conjunctivitis (itching, tearing, erythema)
- Sneezing, nasal/ocular pruritus, watery rhinorrhea
Dosage
| Population | Dose |
|---|
| Adults & children ≥12 yr | 5 mg once daily (evening) |
| Children 6–11 yr | 2.5 mg once daily |
| Renal impairment | Dose reduction required (renally cleared) |
Adverse Effects
- Somnolence (less than older antihistamines, but possible)
- Dry mouth, fatigue, headache
- Rare: QT prolongation (at very high doses)
Contraindications
- Severe renal failure (CrCl <10 mL/min)
- End-stage renal disease on dialysis
- Known hypersensitivity to cetirizine or hydroxyzine
3. The Combination — Rationale
| Component | Role in Combination |
|---|
| Paracetamol 650 mg | Treats fever and body pain |
| Levocetirizine 5 mg | Controls sneezing, runny nose, watery eyes, and allergic itch |
Common brand names (India): Levorid-P, Allercet-P, Lcz-P, Alenex-P, etc.
Typical indication: Upper respiratory tract infections (URTI) / common cold with allergic component — presenting with fever, headache, myalgia + sneezing, rhinorrhea, nasal itching.
4. Key Clinical Points
- Preferred over NSAIDs in viral fevers (dengue, flu) because paracetamol does not inhibit platelet function
- Levocetirizine does not treat nasal congestion well; a decongestant (e.g., pseudoephedrine) may be added if congestion is prominent
- Avoid alcohol with this combination (hepatotoxicity risk from paracetamol; additive CNS depression from levocetirizine)
- Renal caution: Levocetirizine dose must be adjusted in renal impairment
- Not first-line in pregnancy — consult before use; paracetamol is generally considered safer than NSAIDs in pregnancy but prolonged use has been debated
Disclaimer: This information is for educational purposes. Clinical decisions should be made by a qualified healthcare professional based on individual patient assessment.